MedPath

Role of enzyme therapy in treating oral ulcers caused by radiotherapy

Phase 4
Conditions
Health Condition 1: null- Head and neck cancer patients
Registration Number
CTRI/2013/04/003569
Lead Sponsor
Manipal University Postgraduate grant
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
34
Inclusion Criteria

1. Male and female adult subjects, ages, 18-65 years, inclusive

2. Diagnosis of head and neck cancer whose primary mode of treatment is radiation

3. The scheduled dose of radiation should be between 180Cgy to 200Cgy per day, five time a week

4. Willing and able to give written informed consent

5. Karnofsky Performance Status (KPS) >60

Exclusion Criteria

1. Current evidence or history of any clinically significant acute or unstable comorbid conditions

2. History of current, clinically significant mental disorder- or an antagonistic personality that compromises the validity of informed consent

3. History of allergy or sensitivity to drugs

4. Subjects who are pregnant, lactating, breast feeding or planning to conceive

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath